Neogen Chemicals Limited has informed the Exchange about General Updates - Outcome of Board Meeting held on August 2, 2025.
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Neogen Chemicals' board approved its Q1 FY26 (quarter ended June 30, 2025) unaudited results. Standalone revenue from operations rose to Rs 184.58 Cr from Rs 176.34 Cr a year ago, with profit after tax of Rs 14.23 Cr (vs Rs 13.94 Cr). Consolidated revenue was Rs 186.73 Cr with PAT of Rs 10.26 Cr. The 36th AGM is scheduled for September 26, 2025, with September 19, 2025 set as the record date for the final dividend. Founder Chairman & MD Mr. Haridas Kanani will retire on September 30, 2025 and be conferred the honorary title of 'Chairman Emeritus' from October 1, 2025; Mr. Anurag Surana will take over as Non-Executive Chairman, and Mr. Triplicane Commandoor Narasimhan Saikrishnan is recommended as Executive Director. The board also approved an additional Rs 125 Cr corporate guarantee for wholly owned subsidiary Neogen Ionics Limited, and reconstituted key board committees. An update on the March 2025 Dahej plant fire noted receipt of Rs 50 Cr during the quarter and Rs 30 Cr after, reducing the net insurance receivable to Rs 254.06 Cr.
Q1 results show modest year-on-year growth at standalone level and a dip in consolidated PAT, which may keep the stock range-bound. Leadership transition from long-time founder Haridas Kanani to Anurag Surana brings a generational change, while the Rs 125 Cr guarantee for the loss-making Neogen Ionics subsidiary signals continued capital support for the EV battery chemicals venture. Progress on insurance recoveries is a positive for cash flow and balance sheet repair.